Financhill
Back

Hikma Pharmaceuticals PLC Vs. NovoCure Industry Stock Comparison

Sell
43

HKMPF
Hikma Pharmaceuticals PLC

Last Price:
24.87
Seasonality Move:
0.78%
Buy
75

NVCR
NovoCure

Last Price:
33.40
Seasonality Move:
-5.24%
Sell
43
Hikma Pharmaceuticals PLC (HKMPF) is a Sell

Is Hikma Pharmaceuticals PLC a Buy, Sell or Hold?

  • The current Hikma Pharmaceuticals PLC [HKMPF] share price is $24.87. The Score for HKMPF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • HKMPF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HKMPF Stock Price Chart

What is Hikma Pharmaceuticals PLC's stock price today?

  • The Hikma Pharmaceuticals PLC share price today is $24.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HKMPF is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $33.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

HKMPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.18 Buy
Relative Strength Index (14 RSI): 65.79 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.92 - 24.86) Buy
Bollinger Bands (100): (23.94 - 25.92) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.78 Buy
Relative Strength Index (14 RSI): 75.34 Buy
Chaikin Money Flow: 1118573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 28.56) Buy
Bollinger Bands (100): (14.7 - 22.78) Buy

HKMPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.69 Buy
20-day SMA: 23.99 Buy
50-day SMA: 24.49 Buy
200-day SMA: 24.53 Buy
8-day EMA: 24.7 Buy
20-day EMA: 24.4 Buy
50-day EMA: 24.5 Buy
200-day EMA: 24.53 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.6 Buy
20-day SMA: 23.68 Buy
50-day SMA: 19.33 Buy
200-day SMA: 17.9 Buy
8-day EMA: 29.53 Buy
20-day EMA: 25.45 Buy
50-day EMA: 21.38 Buy
200-day EMA: 19.88 Buy

Hikma Pharmaceuticals PLC Earnings Growth & HKMPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Hikma Pharmaceuticals PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):